{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:30:23Z","timestamp":1772307023172,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008312","name":"Fondation Pierre Deniker pour la Recherche et la Pr\u00e9vention en Sant\u00e9 Mentale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.encep.2020.04.010","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T23:09:30Z","timestamp":1588115370000},"page":"S35-S39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"S","title":["Repositionnement de la chlorpromazine dans le traitement du COVID-19\u00a0: \u00e9tude reCoVery"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Plaze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8295-3889","authenticated-orcid":false,"given":"D.","family":"Attali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4143-9848","authenticated-orcid":false,"given":"A.-C.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Blatzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Simon-Loriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vinckier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-4985","authenticated-orcid":false,"given":"A.","family":"Cachia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2020.04.010_bib0215","unstructured":"Situation update worldwide, as of 20\u00a0April 2020. European Centre for Disease Prevention and Control"},{"key":"10.1016\/j.encep.2020.04.010_bib0220","first-page":"112","article-title":"Therapeutic use in psychiatry of phenothiazine of central elective action (4560\u00a0RP)","volume":"110","author":"Delay","year":"1952","journal-title":"Ann Med Psychol (Paris)"},{"key":"10.1016\/j.encep.2020.04.010_bib0225","first-page":"209","article-title":"Influence of chlorpromazine on the replication of influenza virus in chick embryo cells","volume":"26","author":"Krizanov\u00e1","year":"1982","journal-title":"Acta Virol"},{"key":"10.1016\/j.encep.2020.04.010_bib0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00042560-199705010-00003","article-title":"Inhibition of HIV infection of H9\u00a0cells by chlorpromazine derivatives","volume":"15","author":"Hewlett","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.encep.2020.04.010_bib0235","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1128\/JVI.74.5.2288-2292.2000","article-title":"JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis","volume":"74","author":"Pho","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.encep.2020.04.010_bib0240","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1099\/vir.0.18883-0","article-title":"Interference in Japanese encephalitis virus infection of vero cells by a cationic amphiphilic drug, chlorpromazine","volume":"84","author":"Nawa","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.encep.2020.04.010_bib0245","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1128\/JVI.00024-06","article-title":"Hepatitis C virus entry depends on clathrin-mediated endocytosis","volume":"80","author":"Blanchard","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.encep.2020.04.010_bib0250","doi-asserted-by":"crossref","first-page":"e28923","DOI":"10.1371\/journal.pone.0028923","article-title":"Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays","volume":"6","author":"Pohjala","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.encep.2020.04.010_bib0255","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.encep.2020.04.010_bib0260","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.encep.2020.04.010_bib0265","doi-asserted-by":"crossref","first-page":"e0194868","DOI":"10.1371\/journal.pone.0194868","article-title":"MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells","volume":"13","author":"Cong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.encep.2020.04.010_bib0270","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/tra.12272","article-title":"Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis","volume":"16","author":"Daniel","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.encep.2020.04.010_bib0275","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","article-title":"Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation","volume":"123","author":"Wang","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.encep.2020.04.010_bib0280","doi-asserted-by":"crossref","first-page":"e1004502","DOI":"10.1371\/journal.ppat.1004502","article-title":"Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner","volume":"10","author":"Burkard","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.encep.2020.04.010_bib0285","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.7150\/ijbs.45498","article-title":"Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.encep.2020.04.010_bib0290","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138\u00a0hospitalized patients with 2019\u00a0novel coronavirus \u2013 infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.encep.2020.04.010_bib0295","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.encep.2020.04.010_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19\u00a0patients with severe respiratory failure","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.encep.2020.04.010_bib0305","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3956(00)00032-7","article-title":"Effects of antipsychotic drugs on cytokine networks","volume":"34","author":"Pollm\u00e4cher","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.encep.2020.04.010_bib0310","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00005792-199003000-00003","article-title":"Chlorpromazine-induced immunopathy: progressive increase in serum IgM","volume":"69","author":"Zucker","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.encep.2020.04.010_bib0315","first-page":"217","article-title":"Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice","volume":"79","author":"Bertini","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.encep.2020.04.010_bib0320","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.173.6.1305","article-title":"Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock","volume":"173","author":"Gadina","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.encep.2020.04.010_bib0325","first-page":"207","article-title":"Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10\u00a0production, in mice","volume":"82","author":"Mengozzi","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.encep.2020.04.010_bib0330","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.154.2.861","article-title":"Chlorpromazine amplifies macrophage-dependent IL-10\u00a0production in vivo","volume":"154","author":"Tarazona","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.encep.2020.04.010_bib0335","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/0024-3205(83)90742-7","article-title":"Distribution of chlorpromazine and imipramine in adipose and other tissues of rats","volume":"33","author":"Bickel","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.encep.2020.04.010_bib0340","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.2042-7158.1995.tb06741.x","article-title":"Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds","volume":"47","author":"Sgaragli","year":"1995","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.encep.2020.04.010_bib0345","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/0006-2952(68)90180-9","article-title":"Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of death","volume":"17","author":"Forrest","year":"1968","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.encep.2020.04.010_bib0350","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2\u00a0and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study","author":"Chu","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.encep.2020.04.010_bib0355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archpsyc.1981.01780270088012","article-title":"Chlorpromazine levels and the outcome of treatment in schizophrenic patients","volume":"38","author":"May","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2020.04.010_bib0360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/bcp.12785","article-title":"Repurposing some older drugs that cross the blood\u2013brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma","volume":"81","author":"Rundle-Thiele","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.encep.2020.04.010_bib0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19\u00a0and other coronaviruses","author":"Wu","year":"2020","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.encep.2020.04.010_bib0370","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(79)90024-6","article-title":"Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: positron emission tomography studies","volume":"1","author":"Comar","year":"1979","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2020.04.010_bib0375","first-page":"34","article-title":"The distribution of 35S-chlorpromazine in mice studied by whole body autoradiography","volume":"156","author":"Sj\u00f6strand","year":"1965","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.encep.2020.04.010_bib0380","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-3223(92)90085-E","article-title":"Drug distribution between blood and brain as a determinant of antipsychotic drug effects","volume":"32","author":"Tsuneizumi","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2020.04.010_bib0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(76)90061-3","article-title":"The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism","volume":"40","author":"Wiesel","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.encep.2020.04.010_bib0390","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","article-title":"ACOG Practice Bulletin No. 189: nausea and vomiting of pregnancy","volume":"131","author":"Committee on Practice B-O","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.encep.2020.04.010_bib0395","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpainsymman.2012.10.042","article-title":"Nausea and vomiting in advanced cancer \u2013 the Cleveland clinic protocol (TH310)","volume":"45","author":"Gupta","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.encep.2020.04.010_bib0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The acute treatment of migraine in adults: the American Headache Society Evidence Assessment of Migraine Pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.encep.2020.04.010_bib0405","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/head.12287","article-title":"Parenteral treatment of episodic tension-type headache: a systematic review","volume":"54","author":"Weinman","year":"2014","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.encep.2020.04.010_bib0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.984","article-title":"Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity","volume":"9","author":"Kanerva","year":"2007","journal-title":"J Gene Med"},{"key":"10.1016\/j.encep.2020.04.010_bib0415","series-title":"Coronavirus SARS-CoV-2\u00a0: crit\u00e8res cliniques de sortie d\u2019isolement des patients infect\u00e9s","author":"Hcsp","year":"2020"},{"key":"10.1016\/j.encep.2020.04.010_bib0210","unstructured":"WHO. Coronavirus disease (COVID-2019) R&D. WHO, 2020. [Disponible sur\u00a0: https:\/\/www.who.int\/teams\/blueprint\/covid-19]"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700620300798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700620300798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:37:55Z","timestamp":1757957875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700620300798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0013700620300798"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2020.04.010","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repositionnement de la chlorpromazine dans le traitement du COVID-19\u00a0: \u00e9tude reCoVery","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2020.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}